<DOC>
	<DOCNO>NCT03037463</DOCNO>
	<brief_summary>The purpose study ass whether tear secretion patient Parkinson 's disease alter exhibit characteristic diagnostic biomarker profile , reflect change protein composition tear fluid , measure relatively easily , cost-effectively , non-invasively . Tear fluid sample collect Parkinson 's patient , biochemical assay , profile protein tear characterize compare control subject . The profile analyze respect difference Parkinson 's patient control subject . If difference appear , level potential biomarkers Parkinson 's patient compare severity disease .</brief_summary>
	<brief_title>Measuring Parkinson 's Disease With Tear Fluid</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Parkinson 's Disease diagnosis least 2 year Healthy control without neurological illness currently take anticholinergic medication dementia exposure neuroleptic medication Quetiapine Clozapine 6 month prior screen active eye infection eye surgery within 3 month prior screen control subject exclude history neurological disease PD subject excluded atypical Parkinsonian syndrome</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>